Qing MAO, Songtao ZHAO. Concern over global outbreak of acute severe hepatitis of unknown etiology in children[J]. Journal of Army Medical University, 2022, 44(11): 1079-1086.
DOI:
Qing MAO, Songtao ZHAO. Concern over global outbreak of acute severe hepatitis of unknown etiology in children[J]. Journal of Army Medical University, 2022, 44(11): 1079-1086. DOI: 10.16016/j.2097-0927.202205084.
Concern over global outbreak of acute severe hepatitis of unknown etiology in children
Acute severe hepatitis in children of unknown cause is a childhood liver disease of unknown etiology that emerged suddenly during the global pandemic of coronavirus disease 2019. Since it was reported in early April 2022
it has involved more than 20 countries around the world with about 450 cases
mainly in Europe and North America
and no similar case has been reported in China. The disease occurs mostly in children under 5 years of age and is characterized mainly by liver disease manifestations such as jaundice and elevated transaminases
with rare respiratory symptoms; a few cases develop into liver failure and need liver transplantation
and most cases have a good prognosis. The disease is currently considered to be caused by infection
but the exact pathogen remains unclear. Adenovirus is detected in blood in many cases
so the possibility of infection caused by adenovirus should be considered; and factors such as lack of trained immunity and persistent inflammatory in children with COVID-19 should also be considered. The disease is no evidence of interpersonal transmission
infectivity is low
but the possibility of a pandemic outbreak in countries with a high prevalence of COVID-2019 needs to be guarded against; hand hygiene and respiratory protection may reduce the risk of morbidity. This article provides an overview of the epidemiological and clinical features of the disease and analyzes its nature
etiology and transmission risk in order to provide updated awareness of its clinical diagnosis and treatment.
关键词
Keywords
references
World Health Organization. Acute hepatitis of unknown aetiology—the United Kingdom of Great Britain and Northern Ireland[EB/OL](2022-04-15). [2022-05-11]. https://www.who.int/emergencies/disease-outbreak-news/item/acute-hepatitis-of-unknown-aetiology—the-united-kingdom-of-great-britain-and-northern-ireland.
European Centre for Disease Prevention and Control. Increase in severe acute hepatitis cases of unknown aetiology in children[EB/OL](2022-04-28). [2022-04-29]. https://www.ecdc.europa.eu/en/publications-data/increase-severe-acute-hepatitis-cases-unknown-aetiology-children.
Centers for Disease Control and Prevention. Recommendations for adenovirus testing and reporting of children with acute hepatitis of unknown etiology. [EB/OL](2022-04-21). [2022-05-06]. https://emergency.cdc.gov/han/2022/han00462.asp.
European Centre for Disease Prevention and Control. Update: Hepatitis of unknown origin in children. [EB/OL](2022-04-19). [2022-05-11]. https://www.ecdc.europa.eu/en/news-events/update-hepatitis-unknown-origin-children.
World Health Organization. Disease outbreak news: Multi-Country—Acute, severe hepatitis of unknown origin in children. [EB/OL](2022-04-23). [2022-04-23]. https://www.who.int/emergencies/disease-outbreak-news/item/2022-DON376.
European Centre for Disease Prevention and Control. Epidemiological update: Hepatitis of unknown aetiology in children[EB/OL](2022-05-11). [2022-05-16]. Available at: https://www.ecdc.europa.eu/en/news-events/epidemiological-update-hepatitis-unknown-aetiology-children.
Pan American Health Organization/World Health Organization. Acute, severe hepatitis of unknown origin in children. [EB/OL](2022-05-10). [2022-05-16]. https://www.paho.org/en/documents/acute-severe-hepatitis-unknown-origin-children-10-may-2022.
BAKER J M, BUCHFELLNER M, BRITT W, et al . Acute hepatitis and adenovirus infection among children—Alabama, October 2021-February 2022[J ] . MMWR Morb Mortal Wkly Rep , 2022, 71(18): 638-640. DOI:10.15585/mmwr.mm7118e1.
CDC Media. Telebriefing: Update on acute hepatitis of unknown cause. [EB/OL](2022-05-05). [2022-05-16]. https://www.cdc.gov/media/releases/2022/a0505-hepatitis.html.
European Centre for Disease Prevention and Control/WHO Regional Office for Europe. Joint ECDC-WHO Regional Office for Europe Hepatitis of Unknown Origin in Children Surveillance Bulletin[EB/OL](2022-05-13). [2022-05-15]. https://cdn.ecdc.europa.eu/novhep-surveillance/.
UK Health Security Agency.Acute hepatitis: technical briefing. Technical briefing document on the investigation into acute hepatitis cases of unknown aetiology in children in England[EB/OL](2022-05-06). [2022-05-11]. https://www.gov.uk/government/publications/acute-hepatitis-technical-briefing.
ROBINSON C M, SINGH G, LEE J Y, et al . Molecular evolution of human adenoviruses[J ] . Sci Rep, 2013, 3: 1812. DOI:10.1038/srep01812.
LYNCH J, FISHBEIN M, ECHAVARRIA M. Adenovirus[J]. Semin Respir Crit Care Med, 2011, 32(4): 494-511. DOI:10.1055/s-0031-1283287.
LYNCH J P 3rd, KAJON A E. Adenovirus: epidemiology, global spread of novel serotypes, and advances in treatment and prevention[J]. Semin Respir Crit Care Med, 2016, 37(4): 586-602. DOI:10.1055/s-0036-1584923.
MITCHELL L S, TAYLOR B, REIMELS W, et al . Adenovirus 7a: a community-acquired outbreak in a children's hospital[J ] . Pediatr Infect Dis J, 2000, 19(10): 996-1000. DOI:10.1097/00006454-200010000-00011.
OZBAY HO\\U015FNUT F, CANAN O, OZÇAY F, et al . Adenovirus infection as possible cause of acute liver failure in a healthy child: a case report[J ] . Turk J Gastroenterol, 2008, 19(4): 281-283.
ROCHOLL C, GERBER K, DALY J, et al . Adenoviral infections in children: the impact of rapid diagnosis[J ] . Pediatrics, 2004, 113(1 Pt 1): e51-e56. DOI:10.1542/peds.113.1.e51.
HAMOD D A. Adenoviral hepatitis in an immunocompetent child: case report[J]. J Pediatr Neonatal Care, 2017, 7(3): 00290. DOI:10.15406/jpnc.2017.07.00290.
MUNOZ F M, PIEDRA P A, DEMMLER G J. Disseminated adenovirus disease in immunocompromised and immunocompetent children[J]. Clin Infect Dis, 1998, 27(5): 1194-1200. DOI:10.1086/514978.
GÓMARA M I, SIMPSON R, PERAULT A M, et al . Structured surveillance of infantile gastroenteritis in East Anglia, UK: incidence of infection with common viral gastroenteric pathogens[J ] . Epidemiol Infect, 2008, 136(1): 23-33. DOI:10.1017/S0950268807008059.
CUNLIFFE N A, BOOTH J A, ELLIOT C, et al . Healthcare-associated viral gastroenteritis among children in a large pediatric hospital, United Kingdom[J ] . Emerg Infect Dis, 2010, 16(1): 55-62. DOI:10.3201/eid1601.090401.
GYSSENS I C, NETEA M G. Heterologous effects of vaccination and trained immunity[J]. Clin Microbiol Infect, 2019, 25(12): 1457-1458. DOI:10.1016/j.cmi.2019.05.024.
DANG Y P, XIAO J N, WANG Y. Characterization and regulatory function of trained immunity with memory-like phenotypes[J]. Chin Bull Life Sci, 2020, 32(4): 335-342. DOI:10.13376/j.cbls/2020043.
ROBINSON C M, SINGH G, LEE J Y, et al . Molecular evolution of human adenoviruses[J ] . Sci Rep, 2013, 3: 1812. DOI:10.1038/srep01812.
PEREZ A, CANTOR A, RUDOLPH B, et al . Liver involvement in children with SARS-COV-2 infection: two distinct clinical phenotypes caused by the same virus[J ] . Liver Int, 2021, 41(9): 2068-2075. DOI:10.1111/liv.14887.
ANTALA S, DIAMOND T, KOCIOLEK L K, et al . Severe hepatitis in pediatric coronavirus disease 2019[J ] . J Pediatr Gastroenterol Nutr, 2022, 74(5): 631-635. DOI:10.1097/mpg.0000000000003404.
PHETSOUPHANH C, DARLEY D R, WILSON D B, et al . Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection[J ] . Nat Immunol, 2022, 23(2): 210-216. DOI: 10.1038/s41590-021-01113-x.
FAN B E, WONG S W, SUM C L L, et al . Hypercoagulability, endotheliopathy, and inflammation approximating 1 year after recovery: assessing the long-term outcomes in COVID-19 patients[J ] . Am J Hematol, 2022. DOI:10.1002/ajh.26575.Epub ahead of print.
BEHNOOD S A, SHAFRAN R, BENNETT S D, et al . Persistent symptoms following SARS-CoV-2 infection amongst children and young people: a meta-analysis of controlled and uncontrolled studies[J ] . J Infect, 2022, 84(2): 158-170. DOI:10.1016/j.jinf.2021.11.011.
FABI M, FILICE E, BIAGI C, et al . Multisystem inflammatory syndrome following SARS-CoV-2 infection in children: one year after the onset of the pandemic in a high-incidence area[J ] . Viruses, 2021, 13(10): 2022. DOI:10.3390/v13102022.
ZACCHERINI G, WEISS E, MOREAU R. Acute-on-chronic liver failure: Definitions, pathophysiology and principles of treatment[J]. JHEP Rep, 2020, 3(1): 100176. DOI:10.1016/j.jhepr.2020.100176.
BLASCO-ALGORA S, MASEGOSA-ATAZ J, GUTIÉRREZ-GARCÍA M L, et al . Acute-on-chronic liver failure: Pathogenesis, prognostic factors and management[J ] . World J Gastroenterol, 2015, 21(42): 12125-12140. DOI:10.3748/wjg.v21.i42.12125.
WO Y, LU Q B, HUANG D D, et al . Epidemical features of HAdV-3 a nd HAdV-7 in pediatric pneumonia in Chongqing, China[J ] . Arch Virol, 2015, 160(3): 633-638. DOI:10.1007/s00705-014-2308-8.
CAO B, HUANG G H, PU Z H, et al . Emergence of community-acquired adenovirus type 55 as a cause of community-onset pneumonia[J ] . Chest, 2014, 145(1): 79-86. DOI:10.1378/chest.13-1186.
MAO N Y, ZHU Z, LEI Z Q, et al . Continued circulation and phylogenetic analysis of human adenovirus-55 in China during 2006-2016[J ] . Chin J Exp Clin Virol, 2018, 32(2): 124-129. DOI:10.3760/cma.j.issn.1003-9279.2018.02.004.
DUAN Y L, XIE Z D. Prevalence of different genotypes of human adenovirus in patients with respiratory infection in China[J]. Chin J Exp Clin Virol, 2018, 32(4): 430-434. DOI:10.3760/cma.j.issn.1003-9279.2018.04.022.
LU Q B, TONG Y G, WO Y, et al . Epidemiology of human adenovirus and molecular characterization of human adenovirus 55 in China, 2009-2012[J ] . Influe nza Other Respir Viruses, 2014, 8(3): 302-308. DOI:10.1111/irv.12232.
YAO L H, WANG C, WEI T L, et al . Human adenovirus among hospitalized children with respiratory tract infections in Beijing, China, 2017-2018[J ] . Virol J, 2019, 16(1): 78. DOI:10.1186/s12985-019-1185-x.
HUANG Y, WANG C, MA F, et al . Human adenoviruses in paediatric patients with respiratory tract infections in Beijing, China[J ] . Virol J, 2021, 18(1): 191. DOI:10.1186/s12985-021-01661-6.
DUAN Y L, ZHU Y, XU B P, et al . Multicenter study of human adenovirus infection in pediatric community-acquired pneumonia in China[J ] . Chin J Pediatr, 2019, 57(1): 27-32. DOI:10.3760/cma.j.issn.0578-1310.2019.01.008.
CHANG H L, GUO J Y, WEI Z Q, et al . Aetiology of acute diarrhoea in children in Shanghai, 2015-2018[J ] . PLoS One, 2021, 16(4): e0249888. DOI:10.1371/journal.pone.0249888.
SUN L L, JIAO Y, GAO Y, et al . Molecular epidemiology of adenovirus infection among infants with diarrhea in Chaoyang district, Beijing from 2011 to 2017[J ] . Chin J Exp Clin Virol, 2018, 32(5): 492-495. DOI:10.3760/cma.j.issn.1003-9279.2018.05.009.
ZHOU Y H, WU C, ZHUANG H. Vaccination against hepatitis B: the Chinese experience[J]. Chin Med J, 2009, 122(1): 98-102.
TANG J, LUO Y Q, ZHOU Y H. Elimination of hepatitis B virus infection in children: experience and challenge in China[J]. Chin Med J (Engl), 2021, 134(23): 2818-2824. DOI:10.1097/CM9.0000000000001791.
YU H Y, ZHONG Y D, YANG Y F, et al . Analysis of the causes of liver disease in children under 14 years old[J ] . Chin Hepatol, 2021, 26(3): 299-301. DOI:10.14000/j.cnki.issn.1008-1704.2021.03.023.
ZHAO P, WANG C Y, LIU W W, et al . Acute liver failure in Chinese children: a multicenter investigation[J ] . Hepatobil Pancreat Dis Int, 2014, 13(3): 276-280. DOI:10.1016/s149 9-3872(14)60041-2.
National Bureau of Statistics of China. The Seventh National Population Census (No. 5). [R/OL](2021-05-11). [2022-05-16]. http://www.stats.gov.cn/tjsj/zxfb/202105/t20210510_1817181.html.
Publicity Department of National Health Commission of the PRC. Answers to questions about unexplained acute hepatitis in children. EB/OL](2021-05-07). [2022-05-16]. http://www.nhc.gov.cn/xcs/s7847/202205/d1a3f433743144ddaca5e40b232820b1.shtml.
Diagnosis and treatment strategies for Ebola virus disease in children
Causes and clinical features of transient loss of consciousness in 106 children
Safe and effective concentration of ropivacaine in interscalene brachial plexus block for children aged 6 to 10 years: a sequential allocation study
Electrophysiological characteristics and gene analysis of children with congenital stationary night blindness without fundus abnormalities
Treatment and diagnosis for posterior fossa epidural hematomas straddling transverse sinus in children: an analysis of 51 cases
Related Author
陈盛
毛青
向德栋
钱德慧
戴超
晏玲
于佳平
刘慧
Related Institution
Department of Anesthesiology Children’s Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of Child Neurodevelopment and Cognitive Disorders
Department of Ophthalmology, First Affiliated Hospital/Southwest Hospital, Army Medical University (Third Military Medical University)
Department of Neurosurgery, Key Laboratory of Child Development and Disorders of Ministry of Education, Chongqing Key Laboratory of Pediatrics, China International Science and Technology Cooperation Base of Child Development and Critical Disorders, Children's Hospital of Chongqing Medical University
Department of Anesthesiology, Key Laboratory of Child Development and Disorder of Ministry of Education, China International Science and Technology Cooperation Base of Child Development and Critical Disorders, Chongqing Key Laboratory of Pediatrics, Children's Hospital of Chongqing Medical University
Department of Anesthesiology, University-Town Hospital of Chongqing Medical University